Steve Rusckowski

Steve Rusckowski serves as Chairman of Quest Diagnostics, one of the two largest clinical laboratory companies in the United States (alongside Labcorp). Quest processes over 200 million patient samples annually through a network of more than 2,250 patient service centers and a fleet of reference laboratories, offering approximately 3,000 different diagnostic tests ranging from routine blood work to advanced genetic and molecular testing. Quest has been investing in consumer-initiated testing — allowing individuals to order certain lab tests directly through the Quest app or website without a physician's order. This direct-to-consumer approach taps into growing consumer interest in proactive health monitoring and represents a potential expansion of the addressable market beyond physician-ordered testing. The company also provides employer wellness testing, drug testing, and health risk assessments. The clinical laboratory industry benefits from several structural tailwinds: aging population (older patients require more frequent testing), precision medicine (genomic and molecular tests are becoming standard of care), and the growing role of diagnostics in healthcare value-based care models. Key stock drivers include base business testing volumes, advanced diagnostics test mix improvement, consumer-initiated testing growth, reimbursement rates from insurance payers, competition with Labcorp and hospital-based laboratories, the pace of test innovation (particularly in oncology and genomics), and overall U.S. healthcare utilization trends.